Names | |
---|---|
IUPAC name
Tetrasodium 3,3'-[sulfonylbis(benzene-4,1-diylimino)]bis(1-phenylpropane-1,3-disulfonate) | |
Other names
Solapsone; Sulfetrone | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
ECHA InfoCard | 100.004.652 |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C30H28N2Na4O14S5 | |
Molar mass | 892.81 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Solasulfone is an antileprotic drug developed from the parent compound sulphetrone.[1] It was first described and evaluated in the 1930s and 1940s as an antibacterial agent for the treatment of tuberculosis and various other infections, and later found to be effective in the treatment of leprosy.[2]
| |||||||||
---|---|---|---|---|---|---|---|---|---|
Nucleic acid inhibitor |
| ||||||||
Protein synthesis inhibitor |
| ||||||||
Cell envelope antibiotic |
| ||||||||
Other/unknown |
| ||||||||
Combinations |
| ||||||||
|
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |